|
[1] BERG R.Bacterial translocation from the gastrointestinal tract[J].Trends Microbiol, 1995, 3 (4) :149-154.
|
|
[2]LUMSDEN AB, HENDERSON JM, KUTNER MH.Endotoxin levels measured by a chrom ogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis[J].Hepatology, 1988, 8 (2) :232-236.
|
|
[3] BILZER M, ROGGEL F, GERBES AL.Role of Kupffer cells in host defense and liver disease[J].Liver Int, 2006, 26 (10) :1175-1186.
|
|
[4]GALE RP, SPARKES RS, GOLDE DW.Bone marrow origin of hepatic macrophages (Kupffer cells) in humans[J].Science, 1978, 201 (4359) :937-938.
|
|
[5] HELMY KY, KATSCHKE KJ, GORGANI NN, et al.CRIg:a macrophage complement receptor required for phagocytosis of circulating pathogens[J].Cell, 2006, 124 (5) :915-927.
|
|
[6] EBE Y, HASEGAWA G, TAKATSUKA H, et al.The role of Kupffer cells and regulation of neutrophil migration into the liver by macrophage inflammatory protein-2 in primary listeriosis in mice[J].Pathol Int, 1999, 49 (6) :519-532.
|
|
[7]YOU Q, CHENG L, KEDL RM, et al.Mechanism of T cell tolerance induction by murine hepatic Kupffer cells[J].Hepatology, 2008, 48 (3) :978-990.
|
|
[8]LEE WY, MORIARTY TJ, WONG CH, et al.An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells[J].Nat Immunol, 2010, 11 (4) :295-302.
|
|
[9]SHI J, GILBERT GE, KOKUBO Y, et al.Role of the liver in regulating numbers of circulating neutrophils[J].Blood, 2001, 98 (4) :1226-1230.
|
|
[10] BOLTJES A, MOVITA D, BOONSTRA A, et al.The role of Kupffer cells in hepatitis B and hepatitis C virus infections[J].J Hepatol, 2014, 61 (3) :660-671.
|
|
[11]RACANELLI V, REHERMANN B.The liver as an immunological organ[J].Hepatology, 2006, 43 (2 Suppl 1) :s54-s62.
|
|
[12] WU J, MENG Z, JIANG M, et al.Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific[J].Immunology, 2010, 129 (3) :363-374.
|
|
[13]NAHMIAS Y, CASALI M, BARBE L, et al.Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes[J].Hepatology, 2006, 43 (2) :257-265.
|
|
[14]BALAM S, ROMERO JF, BONGFEN SE, et al.C SP-a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes[J].PLoS One, 2012, 7 (12) :e51875.
|
|
[15]FENG G, ZHANG JY, ZENG QL, et al.Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells[J].Hepatol Res, 2013.[Epub ahead of print]
|
|
[16] WINAU F, HEGASY G, WEISKIRCHEN R, et al.Ito cells are liver-resident antigen-presenting cells for activating T cell responses[J].Immunity, 2007, 26 (1) :117-129.
|
|
[17]STEPTOE RJ, FU F, LI W, et al.Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity[J].J Immunol, 1997, 159 (11) :5483-5491.
|
|
[18]KUDO S, MATSUNO K, EZAKI T, et al.A novel migration pathway for rat dendritic cells from the blood:hepatic sinusoids-lymph translocation[J].J Exp Med, 1997, 185 (4) :777-784.
|
|
[19] ZHENG JM, SHI GF, LI N, et al.Study on type I interferon and phospho-IRF3 in murine liver dendritic cells after intervened by HBV[J].Chin J Hepatol, 2011, 19 (6) :450-453. (in Chinese) 郑建铭, 施光峰, 李宁, 等.乙型肝炎病毒干预后小鼠肝脏树突状细胞P-干扰素调节因子3表达的研究[J].中华肝脏病杂志, 2011, 19 (6) :450-453.
|
|
[20]GOLDEN-MASON L, COX AL, RANDALL JA, et al.Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro[J].Hepatology, 2010, 52 (5) :1581-1589.
|
|
[21]ZEISSIG S, MURATA K, SWEET L, et al.Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity[J].Nat Med, 2012, 18 (7) :1060-1068.
|
|
[22]YAMAGIWA S, MATSUDA Y, ICHIDA T, et al.Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells[J].Hepatol Res, 2008, 38 (7) :664-672.
|
|
[23] DIAO H, HE J, ZHENG Q, et al.A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment[J].Immunol Lett, 2014, 160 (1) :65-71.
|
|
[24] JENNE CN, WONG CH, ZEMP FJ, et al.Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps[J].Cell Host Microbe, 2013, 13 (2) :169-180.
|
|
[25]IANNACONE M, SITIA G, ISOGAWA M, et al.Platelets mediate cytotoxic T lymphocyte-induced liver damage[J].Nat Med, 2005, 11 (11) :1167-1169.
|
|
[26]SCHFER G, GULER R, MURRAY G, et al.The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model[J].PLoS One, 2009, 4 (12) :e8448.
|
|
[27]EYRE NS, DRUMMER HE, BEARD MR.The SR-BI partner PDZK1 facilitates hepatitis C virus entry[J].PLoS Pathog, 2010, 6 (10) :e1001130.
|
|
[28] WU J, MENG Z, JIANG M, et al.Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific[J].Immunology, 2010, 129 (3) :363-374.
|
|
[29]WILKINS C, WOODWARD J, LAU DT, et al.IFITM1 is a tight junction protein that inhibits hepatitis C virus entry[J].Hepatology, 2013, 57 (2) :461-469.
|
|
[30]BERG M, WINGENDER G, DJANDJI D, et al.Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+T cell tolerance[J].Eur J Immunol, 2006, 36 (11) :2960-2970.
|
|
[31]SEKI E, BRENNER DA.Toll-like receptors and adaptor molecules in liver disease:update[J].Hepatology, 2008, 48 (1) :322-335.引证本文:YE CT, WEI X, ZHANG Y.Current status of research on liver innate immunity[J].J Clin Hepatol, 2014, 30 (9) :846-850. (in Chinese) 叶传涛, 魏欣, 张颖.肝脏固有免疫系统研究现状[J].临床肝胆病杂志, 2014, 30 (9) :846-850.
|
DownLoad: